UBS Raises Regeneron Price Target to $978 From $660
UBS raised its rating on Regeneron to Buy from Neutral.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
UBS raised its rating on Regeneron to Buy from Neutral.